Lind Opens Second Charlotte Office in Pearl
The AI company's new office at Connect Labs by Wexford sits in Charlotte's Pearl Innovation District, alongside an expanded partnership with Advocate Health.
Updated on Nov. 20, 2026 in Biotech

Lind, an AI company, opened its second office in the Pearl Innovation District in Charlotte. The move comes alongside an expanded partnership with Advocate Health to grow Lind's clinical trial AI platform.
Why it matters
The expansion extends Lind's work with Advocate Health on matching cancer patients to clinical trials, a process that relies on AI to identify eligible patients. For Charlotte, it adds to the research and innovation activity in the Pearl district.
The expanded platform will support study feasibility, patient identification, screening, enrollment coordination and portfolio analytics. The extraction does not specify performance metrics or technical capacity for the platform.
The players
Lind
Lind is an AI company that builds a platform for clinical trial matching and related research operations.
Advocate Health
Advocate Health is a health system based in Charlotte, North Carolina, that co-developed the Pearl Innovation District with Wexford Science & Technology.
The details
Lind's new office is located at Connect Labs by Wexford in the Pearl Innovation District, which was developed through a public-private partnership between Advocate Health and Wexford Science & Technology. The expanded partnership will grow Lind's AI platform used to identify and match cancer patients with clinical trials, and the closer location is intended to speed feedback from research coordinators, investigators and research leaders.
Timeline
May: Partnership to use Lind's AI to match cancer patients with clinical trials was announced.
Nov. 20: News release announcing the expanded partnership and second office.
The Tech Race
The Pearl Innovation District was built through a public-private partnership between Advocate Health and Wexford Science & Technology, and Lind's office extends that model by bringing a clinical AI company into the development. The move positions Charlotte as a site for health-focused AI firms competing to speed up clinical trial enrollment.
For patients with cancer in the Charlotte area, the partnership is aimed at identifying and matching them with clinical trials more efficiently. The extraction does not confirm when or whether the platform will be available to individual patients.
The takeaway
Clinical trial access depends heavily on matching patients to studies quickly, and placing AI development near research teams is one approach companies are testing. Readers interested in trial participation can ask their care providers about current studies.
Further reading
Explore more Biotech developments shaping clinical research in Charlotte.
Source note: This article includes information reported by Becker's Hospital Review | Healthcare News & Analysis.






